Navigation Links
PDI Appoints Gerald P. Belle as Lead Independent Director
Date:7/30/2009

SADDLE RIVER, N.J., July 30 /PRNewswire-FirstCall/ -- PDI, Inc. (Nasdaq: PDII), a leading provider of sales and marketing support to U.S. pharmaceutical companies, announced today that current PDI director Gerald P. Belle has been appointed to the newly-established position of lead independent director.

Mr. Belle has been a director of the Company since April 2008. He is also a member of the Audit Committee.

"Jerry has served as an invaluable board member during his tenure with PDI," stated John P. Dugan, Chairman of the Board of PDI, Inc. "In his expanded role, we believe Jerry's experience, knowledge and leadership skills will further enhance the Company's corporate governance structure. We look forward to his continuing contributions."

"I am delighted to accept this new appointment as lead director of PDI, especially as the Company continues to expand its strong presence in the industry and the value proposition it brings to its customers in an ever-changing environment. As such, I look forward to working with PDI management and my fellow board members who remain committed to helping achieve the Company's growth goals while maintaining the highest standards of corporate governance," stated Mr. Belle.

From 2004 until his retirement in November 2007, Mr. Belle served as Executive Chairman of Merial Ltd., a global animal health company that is a joint venture between Sanofi-aventis and Merck & Co. Prior to that, Mr. Belle served as President and Chief Executive Officer, North America Pharmaceuticals for Aventis, Inc. He retired after 35 years of service at Aventis and its predecessor companies. Mr. Belle is Chairman of the Board of Myriad Pharmaceuticals, Inc., a publicly traded biopharmaceutical company and also a member of the board of directors of Myriad Genetics, Inc.,
'/>"/>

SOURCE PDI, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
2. Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer
3. Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board
4. FlowCardia, Inc. Appoints Chris Barys to Chief Operating Officer
5. Exosome Diagnostics Appoints Former Roche Executive Greg Zdechlik as Chief Operating Officer
6. ERT Appoints New Vice President of Project Management
7. NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
8. Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
9. Progenitor Cell Therapy Appoints VP of Manufacturing Operations
10. Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
11. Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... April 21, 2015 The North American chromatography systems ... from 2014 to 2019. Based on geography, this market has ... and Mexico . The U.S. accounted for ... . The major factors driving the growth of chromatography systems ... industries are the prime users of chromatography techniques. ...
(Date:4/21/2015)... WORTH, Texas , April 21, 2015 ... to grow from $313.0 million in 2014 to $605.1 million ... period under consideration. Browse through the TOC ... for an in-depth analysis of the industry trends and ... http://www.micromarketmonitor.com/market/north-america-bio-stimulants-6850160039.html Early buyers ...
(Date:4/21/2015)... , April 21, 2015  Scientists from the ... research organization, published a paper today outlining new ... microalgae called diatoms. The researchers, led by first ... author Philip Weyman , Ph.D., conclude that ... understanding of diatom genetics and thus facilitate advances ...
(Date:4/21/2015)... Invetech , a global leader ... contract manufacturing, and  NanoCellect Biomedical, a company ... sorting technology for life science researchers, today announced ... platform. Headquartered in San ... microchip-based cell sorting technology. NanoCellect,s flow cytometry platform ...
Breaking Biology Technology:North American Chromatography systems Market by Types, & by End-Users - Forecast to 2019 2North American Chromatography systems Market by Types, & by End-Users - Forecast to 2019 3North America Biostimulants Market is Expected to Reach $605.1 Million by 2019, at a CAGR of 14.1% From 2014 to 2019 2North America Biostimulants Market is Expected to Reach $605.1 Million by 2019, at a CAGR of 14.1% From 2014 to 2019 3Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 2Scientists at the J. Craig Venter Institute Publish Paper Outlining Efficient Synthetic Biology Methods to Genetically Engineer Microalgae 3NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 2NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 3
... New York on Monday, September 10th, SAN ... biopharmaceutical company developing patient-specific, active,immunotherapies for the treatment ... President and Chief Executive Officer, will present at,the ... p.m. Eastern,time on Monday, September 10, 2007. The ...
... CDC to Ensure US,s Preparedness ... Emergency, CAMBRIDGE, England and CAMBRIDGE, Massachusetts, September ... company, announced today that the US Food and ... Vaccine, Live) vaccine,for protection against smallpox. The vaccine ...
... announced,today that one year findings from the ... net clinical benefit for patients with acute,ST-segment ... Heparin (UFH). The ExTRACT-TIMI 25 and ... sessions at the European Society of Cardiology ...
Cached Biology Technology:FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 2FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 3FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 4FDA Approves ACAM2000(TM) Vaccine for Protection Against Smallpox 5New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 2New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 3New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 4New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 5
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
(Date:4/2/2015)... HAMBURG, Germany , April 2, 2015 /PRNewswire/ ... ten fingerprint tests DERMALOG by far outperforms the ... While always maintaining high accuracy, the system is ... second. Hence, the speed proves up to be ... 40% faster than its runner-up performance. ...
(Date:4/1/2015)... 1, 2015   Medisafe ™, the leading global ... iOS and Android smartphones and ... into the platform to allow patients to track and ... first time, patients will be able to visualize in ... important biometrics, such as glucose levels and blood pressure. ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... weapon in the arsenal against cancer: Nanoparticles that identify, ... cells alone. Led by Carl Batt, the Liberty ... nanoparticles shaped something like a dumbbell made ... They then attached antibodies, which target a molecule found ...
... of God and the nature of religion, two distinguished ... in evolutionary biology with a focus on brain science, ... Tiger and pioneering neuroscientist Michael McGuire elucidate perennial questions ... arise? What is its source? And why does every ...
... breakthrough treatments for the most common cancers could soon come ... At the ESMO Conference on Sarcoma and GIST, to ... 2010, researchers and some of the world,s leading experts will ... found in muscle, blood vessels, deep skin tissues, nerves and ...
Cached Biology News:Like little golden assassins, 'smart' nanoparticles identify, target and kill cancer cells 2Which came first: Religion or the brain? 2Spotlight on rare tumors in hunt for new cancer treatments 2
EoProbe Eosinophil Staining Kit, 1 Kit...
B.D. Hames and D.M. Glover (1996) • This issue covers T-Cell antigen receptor genes; T-Lymphocyte signal transduction; B-Cell activation antibody engineering and the complement system and other ...
...
LabFax: Immunochemistry...
Biology Products: